PR Newswire KELOWNA, British Columbia, May 8, 2017, MRPHF KELOWNA, British Columbia, May 8, 2017 /PRNewswire/ — Marapharm Ventures Inc. (OTCQB: MRPHF) (CSE: MDM.CN) (FSE: 2MO) (‘Marapharm’ or the ‘Company’) (http://www.marapharm.com/) was listed on the CSE and began trading on May 8, 2015, with subsequent listings on the OTCQB and the FSE. Marapharm has raised $22,917,150.00 (share source: Computer Share; Transfer Agent). The proceeds have been raised by private placements, and the exercise of options and warrants as a publicRead more
- Research on Lodonal for HIV related GI complications featured in Plus Magazine
- Cannabis Strategic Ventures and Sunniva Inc. Enter Into Cannabis Extraction Services Agreement
- Precision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment Strategies
- Precision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal System
- PHI Group Partners with Fintech Green Investment Company
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More